SULLIVAN LOUIS W
Known title: DirectorCIK: 0001193522
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 6, 2026
EBS Shares Rise 14.4% After Russia Plague Lab Worker Death. EBS stock jumped 14.4% following the death of a Russian plague laboratory worker, a move that also lifted other vaccine makers such as Novavax, Arcturus and Moderna. The rally has drawn attention from retail traders who are looking for potential contract awards. The shares are currently trading near the $7.98 support level, which has been tested 20 times, and the RSI sits at 55.1, indicating neither overbought nor oversold conditions.
Transaction History
| UTHR | ▲ Buy | Option Exercise | 650 | $0 | 7/9/2026 | View on chart |
| UTHR | ▲ Buy | Option Exercise | 3,230 | $594K | 12/22/2025 | View on chart |
| UTHR | ▲ Buy | Option Exercise | 2,720 | $625K | 12/22/2025 | View on chart |
| UTHR | ▼ Sell | Open Market | 4,863 | $2.5M | 12/22/2025 | View on chart |
| UTHR | ▼ Sell | Open Market | 1,087 | $556K | 12/22/2025 | View on chart |
| UTHR | ▲ Buy | Option Exercise | 590 | $0 | 7/25/2025 | View on chart |
| EBS | ▲ Buy | Grant | 34,403 | $0 | 4/30/2025 | View on chart |
| UTHR | ▼ Sell | Gift | 1,851 | $0 | 12/19/2024 | View on chart |
| UTHR | ▲ Buy | Option Exercise | 15,000 | $2.6M | 12/18/2024 | View on chart |
| UTHR | ▼ Sell | Open Market | 1,121 | $410K | 12/18/2024 | View on chart |
| UTHR | ▼ Sell | Open Market | 600 | $220K | 12/18/2024 | View on chart |
| UTHR | ▼ Sell | Open Market | 1,307 | $482K | 12/18/2024 | View on chart |
| UTHR | ▼ Sell | Open Market | 2,100 | $776K | 12/18/2024 | View on chart |
| UTHR | ▼ Sell | Open Market | 700 | $266K | 12/18/2024 | View on chart |
| UTHR | ▼ Sell | Open Market | 1,400 | $518K | 12/18/2024 | View on chart |
| UTHR | ▼ Sell | Open Market | 1,501 | $560K | 12/18/2024 | View on chart |
| UTHR | ▼ Sell | Open Market | 200 | $74K | 12/18/2024 | View on chart |
| UTHR | ▼ Sell | Open Market | 2,451 | $917K | 12/18/2024 | View on chart |
| UTHR | ▼ Sell | Open Market | 2,200 | $825K | 12/18/2024 | View on chart |
| UTHR | ▼ Sell | Open Market | 500 | $187K | 12/18/2024 | View on chart |
| UTHR | ▼ Sell | Open Market | 200 | $76K | 12/18/2024 | View on chart |
| UTHR | ▼ Sell | Open Market | 620 | $236K | 12/18/2024 | View on chart |
| UTHR | ▼ Sell | Open Market | 100 | $38K | 12/18/2024 | View on chart |
| UTHR | ▼ Sell | Open Market | 752 | $277K | 12/18/2024 | View on chart |
| UTHR | ▼ Sell | Open Market | 1,926 | $713K | 12/18/2024 | View on chart |
| UTHR | ▼ Sell | Open Market | 100 | $37K | 12/18/2024 | View on chart |
| UTHR | ▼ Sell | Open Market | 1,525 | $569K | 12/18/2024 | View on chart |
| UTHR | ▼ Sell | Open Market | 1,962 | $734K | 12/18/2024 | View on chart |
| UTHR | ▼ Sell | Open Market | 2,700 | $1.0M | 12/18/2024 | View on chart |
| UTHR | ▼ Sell | Open Market | 400 | $151K | 12/18/2024 | View on chart |
| UTHR | ▼ Sell | Open Market | 944 | $358K | 12/18/2024 | View on chart |
| UTHR | ▼ Sell | Open Market | 800 | $305K | 12/18/2024 | View on chart |
| UTHR | ▼ Sell | Open Market | 100 | $38K | 12/18/2024 | View on chart |
| EBS | ▲ Buy | Grant | 17,430 | $0 | 5/23/2024 | View on chart |
| UTHR | ▼ Sell | Open Market | 2,979 | $772K | 5/3/2024 | View on chart |
| UTHR | ▼ Sell | Open Market | 2,181 | $561K | 5/3/2024 | View on chart |
| UTHR | ▲ Buy | Option Exercise | 5,160 | $618K | 5/3/2024 | View on chart |
| UTHR | ▲ Buy | Option Exercise | 880 | $0 | 7/7/2023 | View on chart |
| EBS | ▲ Buy | Grant | 33,847 | $0 | 5/25/2023 | View on chart |
| UTHR | ▲ Buy | Option Exercise | 700 | $93K | 3/1/2023 | View on chart |
| UTHR | ▼ Sell | Open Market | 700 | $172K | 3/1/2023 | View on chart |
| UTHR | ▲ Buy | Option Exercise | 700 | $93K | 2/1/2023 | View on chart |
| UTHR | ▼ Sell | Open Market | 700 | $183K | 2/1/2023 | View on chart |
| UTHR | ▲ Buy | Option Exercise | 700 | $93K | 1/3/2023 | View on chart |
| UTHR | ▼ Sell | Open Market | 700 | $193K | 1/3/2023 | View on chart |
| UTHR | ▲ Buy | Option Exercise | 700 | $93K | 12/1/2022 | View on chart |
| UTHR | ▼ Sell | Open Market | 700 | $196K | 12/1/2022 | View on chart |
| UTHR | ▲ Buy | Option Exercise | 700 | $93K | 11/1/2022 | View on chart |
| UTHR | ▼ Sell | Open Market | 700 | $161K | 11/1/2022 | View on chart |
| UTHR | ▼ Sell | Open Market | 710 | $150K | 10/3/2022 | View on chart |
| UTHR | ▲ Buy | Option Exercise | 710 | $94K | 10/3/2022 | View on chart |
| UTHR | ▲ Buy | Option Exercise | 4,910 | $500K | 9/2/2022 | View on chart |
| UTHR | ▼ Sell | Open Market | 4,910 | $1.1M | 9/2/2022 | View on chart |
| UTHR | ▲ Buy | Option Exercise | 3,230 | $0 | 7/8/2022 | View on chart |
| UTHR | ▲ Buy | Option Exercise | 6,310 | $482K | 5/26/2022 | View on chart |
| UTHR | ▼ Sell | Open Market | 1,766 | $396K | 5/26/2022 | View on chart |
| UTHR | ▼ Sell | Open Market | 1,500 | $339K | 5/26/2022 | View on chart |
| UTHR | ▼ Sell | Open Market | 1,345 | $305K | 5/26/2022 | View on chart |
| EBS | ▲ Buy | Grant | 8,446 | $0 | 5/26/2022 | View on chart |
| UTHR | ▼ Sell | Open Market | 1,699 | $380K | 5/26/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
United Therapeutics Settles Litigation, Market Reassesses Valuation
United Therapeutics has settled a litigation that impacts its pulmonary hypertension business. The settlement resets competition in that market and has led analysts to question whether the stock is undervalued. The move may prompt a reassessment of the company’s value by investors.
United Therapeutics Settles Litigation, Market Reassesses Valuation. United Therapeutics has settled a litigation that impacts its pulmonary hypertension business. The settlement resets competition in that market and has led analysts to question whether the stock is undervalued. The move may prompt a reassessment of the company’s value by investors.